Articles
Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT
Gaba P, Bhatt DL, Mason RP, et al.
Journal:
J Clin Lipidol
First published: June 4, 2022 DOI: 10.1016/j.jacl.2022.05.067